- Home
- TAYD vs PROK Comparison
TAYD vs PROK Comparison
Compare TAYD & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAYD
- PROK
- Stock Information
- Founded
- TAYD 1955
- PROK 2015
- Country
- TAYD United States
- PROK United States
- Employees
- TAYD N/A
- PROK N/A
- Industry
- TAYD Industrial Machinery/Components
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TAYD Industrials
- PROK Health Care
- Exchange
- TAYD Nasdaq
- PROK Nasdaq
- Market Cap
- TAYD 114.6M
- PROK 94.9M
- IPO Year
- TAYD N/A
- PROK N/A
- Fundamental
- Price
- TAYD $35.47
- PROK $0.84
- Analyst Decision
- TAYD
- PROK Buy
- Analyst Count
- TAYD 0
- PROK 4
- Target Price
- TAYD N/A
- PROK $5.00
- AVG Volume (30 Days)
- TAYD 12.2K
- PROK 519.1K
- Earning Date
- TAYD 08-14-2025
- PROK 08-08-2025
- Dividend Yield
- TAYD N/A
- PROK N/A
- EPS Growth
- TAYD 1.48
- PROK N/A
- EPS
- TAYD 2.50
- PROK N/A
- Revenue
- TAYD $42,796,782.00
- PROK $306,000.00
- Revenue This Year
- TAYD $15.06
- PROK $54.34
- Revenue Next Year
- TAYD $8.37
- PROK N/A
- P/E Ratio
- TAYD $14.17
- PROK N/A
- Revenue Growth
- TAYD N/A
- PROK N/A
- 52 Week Low
- TAYD $29.50
- PROK $0.46
- 52 Week High
- TAYD $64.50
- PROK $3.05
- Technical
- Relative Strength Index (RSI)
- TAYD 47.30
- PROK 50.38
- Support Level
- TAYD $33.67
- PROK $0.75
- Resistance Level
- TAYD $36.71
- PROK $1.05
- Average True Range (ATR)
- TAYD 1.47
- PROK 0.08
- MACD
- TAYD -0.34
- PROK 0.02
- Stochastic Oscillator
- TAYD 41.57
- PROK 42.47
About TAYD Taylor Devices Inc.
Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.